Clinical Trial Update: Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ACE inhibition in children with mitral regurgitation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Heart Failure
• Mitral Regurgitation
• Ventricular Septal Defect

Snippet

Sponsor: University of Utah | Conditions: Heart Defects, Congenital, Heart Septal Defects, Ventricular | Phase 3 | Status: TERMINATED